Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

SHBG may be a useful early indicator and treatment target for PCOS.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Flutamide reduces hair growth better but has more side effects.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.